Medinotec Inc.
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, … Read more
Medinotec Inc. (MDNC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: 0.102x
Based on the latest financial reports, Medinotec Inc. (MDNC) has a cash flow conversion efficiency ratio of 0.102x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($563.14K) by net assets ($5.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medinotec Inc. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Medinotec Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medinotec Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medinotec Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sunrise New Energy Co. Ltd
NASDAQ:EPOW
|
-0.678x |
|
Tri Viet Securities Joint Stock Corp
VN:TVB
|
N/A |
|
Falcon Metals Limited
PINK:FALFF
|
0.000x |
|
Barunson Entertainment & Arts Corporation
KQ:035620
|
-0.036x |
|
Thai Nippon Rubber Industry Public Co. Ltd
BK:TNR
|
0.025x |
|
Scope Industries Bhd
KLSE:0028
|
0.052x |
|
MONOLITHIC POWER (NQG.SG)
STU:NQG
|
0.099x |
|
Censof Holdings Bhd
KLSE:5195
|
0.051x |
Annual Cash Flow Conversion Efficiency for Medinotec Inc. (2022–2025)
The table below shows the annual cash flow conversion efficiency of Medinotec Inc. from 2022 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-02-28 | $4.27 Million | $877.83K | 0.206x | +3027.68% |
| 2024-02-29 | $2.17 Million | $14.24K | 0.007x | +103.42% |
| 2023-02-28 | $2.56 Million | $-490.55K | -0.192x | -12422.11% |
| 2022-02-28 | $-469.99K | $-732.00 | 0.002x | -- |